Provexis PLC (PXS)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.525p

Buy

0.62p

arrow-up0.00p (+0.00%)

Prices updated at 09 May 2025, 16:35 BST

Prices minimum 15 mins delay

Prices in GBX

Provexis PLC is engaged in developing and licensing the proprietary Fruitflow, which is a heart-health functional food ingredient for the functional food sector.

FTSE All-Share

0.27%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Mr. Charles Dawson Buck

CEO

-

Most recent earnings

31 Mar 2024

Fiscal year end

31 Mar 2024

Employees

-

Head office

2 Blagrave Street

Reading

United Kingdom

RG1 1AZ

+44 7490391888

enquiries@provexis.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Charles Dawson Buck Non-Executive Director, Chairman	-
Dr. Niamh Ann O'Kennedy Executive Director, Chief Scientific Officer	-
Mr. Ian Ford Executive Director, CFO, CEO and Secretary	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
No data

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.